Shayesteh Fürst-Ladani is the CEO and founder of SFL. She leads the team at SFL and provides global strategic support for the development of drugs, medical devices, in vitro diagnostics (IVDs), combination products, and borderline products. Shayesteh is President of the Swiss Association “Rare Disease Action Forum” (RDAF) as well as the “Medtech & Pharma Platform” Association.
Before founding SFL, Shayesteh hold senior positions in various biotech and major pharmaceutical companies as Head of Global Regulatory Affairs and Head of Regulatory Affairs for Development Products. Shayesteh is Adjunct Instructor for Regulatory Affairs at the George Washington University School of Medicines and Health Sciences.
She received her MSc in Microbiology from the University of Vienna, Austria, and a MBA from the Open University Business School, Milton Keynes, UK.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).